Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-156689
Filing Date
2023-05-30
Accepted
2023-05-30 17:00:32
Documents
2
Group Members
BCIP LIFE SCIENCES ASSOCIATES, LPBCLS I INVESTCO, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d513015dsc13ga.htm SC 13G/A 83046
2 EX-99.A d513015dex99a.htm EX-99.A 12287
  Complete submission text file 0001193125-23-156689.txt   96923
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Subject) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91583 | Film No.: 23977453
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 617-516-2000
Bain Capital Life Sciences Fund, L.P. (Filed by) CIK: 0001687968 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A